Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 19Breast Neoplasms 16Pain 8Agnosia 8Lung Neoplasms 6Prostatic Neoplasms 5Neoplasms 5Stomach Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 3Supratentorial Neoplasms 2Postoperative Complications 2Meningioma 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Sleep Deprivation 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pain, Intractable 1Ovarian Cysts 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Malignant Neoplasms of Male Genital Organs 1Liver Neoplasms 1Liver Diseases 1Leiomyoma 1Kidney Neoplasms 1Intraoperative Complications 1

Interventions

Ropivacaine 1Lidocaine 1Animal Assisted Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Feeding and Eating Disorders × Ropivacaine × Clear all
NCT04250805 2024-01-31

GASTROXY

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Terminated
17 enrolled

Feeding and Eating Disorders, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡